300272.SZ
开能健康
SZSE · Industrials · C 制造业 · CN
CNY 5.73
−2.39%Year over year
Reported trailing growth
- Revenue
- +5.1%
- EBITDA
- —
- EBIT
- -30.9%
- EPS
- -40.5%
- Free cash flow
- -40.8%
- Operating cash flow
- -28.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.5%
- EBITDA
- +1.9%
- EBIT
- -0.8%
- Net income
- -15.4%
- EPS
- -15.5%
- Free cash flow
- +36.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026